Crossmark

Prognosis of patients with Hodgkin lymphoma and indeterminate response to PD-1 inhibitor therapy: considerations for application of LYRIC criteria in real clinical practice

Crossref DOI link: https://doi.org/10.1007/s00277-024-06091-2

Published Online: 2024-11-19

Published Print: 2024-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Fedorova, Liudmila https://orcid.org/0000-0002-3275-219X
Lepik, Kirill

Gusak, Artem

Kotselyabina, Polina

Moiseev, Ivan

Baykov, Vadim

Mikhailova, Natalia

Kulagin, Alexander
License Information

Text and Data Mining valid from 2024-11-19

Version of Record valid from 2024-11-19
More Information

Article History

Received: 7 August 2024

Accepted: 8 November 2024

First Online: 19 November 2024

Declarations

:

: This study was performed in accordance with the 1964 Helsinki declaration and approved by Pavlov University Ethics Committee. All enrolled patients gave written informed consent.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below